NCT04259190

Brief Summary

The purpose of the current study is to examine the effect of emphasizing values in the treatment rationale on treatment response, willingness to tolerate distress, and acceptability of a one-session interoceptive exposure intervention for the reduction of anxiety sensitivity. A standard treatment rationale without values emphasis will serve as a control.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 6, 2020

Completed
2.3 years until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2022

Completed
Last Updated

June 26, 2020

Status Verified

June 1, 2020

Enrollment Period

3 months

First QC Date

January 31, 2020

Last Update Submit

June 24, 2020

Conditions

Keywords

anxiety sensitivitypanicinteroceptive exposureexposure therapyvalues

Outcome Measures

Primary Outcomes (1)

  • Willingness to tolerate distress

    Willingness to tolerate distress will be assessed by identifying the activity item on the Albany Panic and Phobia Questionnaire (APPQ) - Agoraphobia subscale to which the participant responded with the highest score indicating most fear. The participant will then be asked, "How willing would you be to do \[most feared activity\] next week?" Responses will range from 0% to 100%.

    change from pre-intervention to immediately post-intervention

Secondary Outcomes (7)

  • Straw breathing BAT peak fear ratings

    pre-intervention

  • Overbreathing BAT peak fear ratings

    immediately post-intervention

  • Between trial fear ratings

    change from pre-intervention to immediately post-intervention

  • Anxiety Sensitivity Index - 3 (ASI-3)

    change from pre-intervention to immediately post-intervention

  • Albany Panic and Phobia Questionnaire (APPQ)

    change from pre-intervention to immediately post-intervention

  • +2 more secondary outcomes

Study Arms (2)

Values rationale

EXPERIMENTAL

Interoceptive exposure exercises will be introduced as a way to help participants engage in more that they value.

Behavioral: interoceptive exposure

Standard rationale

ACTIVE COMPARATOR

Interoceptive exposure exercises will be introduced as a way to help participants experience less discomfort.

Behavioral: interoceptive exposure

Interventions

Repeated 60-second trials of voluntary hyperventilation, each followed by a 15-second rest period. Participants will complete a minimum of 8 trials and continue additional trials until ratings of their most feared predicted outcome fall less than or below 5% likelihood.

Standard rationaleValues rationale

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Score ≥ 23 on the Anxiety Sensitivity Index - 3 (ASI-3)

You may not qualify if:

  • Seizures
  • Hypertension
  • Heart problems
  • Current pregnancy
  • Asthma
  • Other health conditions exacerbated by intense exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Mississippi

University, Mississippi, 38677, United States

Location

Study Officials

  • Gina Boullion, M.S.

    University of Mississippi Medical Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Doctoral Candidate

Study Record Dates

First Submitted

January 31, 2020

First Posted

February 6, 2020

Study Start

June 1, 2022

Primary Completion

August 30, 2022

Study Completion

August 30, 2022

Last Updated

June 26, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations